News

Number of new prostate cancer cases per 100,000 men: 114.9 white men; 188.7 black men.

An Improved Prostate Cancer Biomarker Test May Help Men Avoid Unnecessary Biopsy

POSTED: April 29, 2024
SOURCE: Cancer Prevention Science Blog
AUTHOR: Alyssa M. Voss, M.P.H.

Researchers funded by NCI have developed and validated a new prostate cancer urinary biomarker test that can help differentiate who should proceed for biopsy after an elevated prostate-specific antigen (PSA) test from those…
Virus particles surround three human figures with their livers highlighted. One figure has a healthy liver, one has chronic liver disease and one has liver cancer.
NIH scientists develop blood test to help improve liver cancer screening
Scientists have developed a new test that can help identify people who are likely to develop hepatocellular carcinoma (HCC), the most common form of liver cancer. The approach uses a simple blood test to check for the patient’s previous exposure to certain viruses. A study of the new approach was… Learn more
POSTED: 6/11/2020
SOURCE: NCI Press Release
EsoCheck and EsoGuard infographic
New Technology Gives Patients Access to a 5-Minute, Office-Based Test to Identify Risk for Esophageal Cancer
EsoCheck™ and EsoGuard™ NCI Annual Plan & Budget Proposal for Fiscal Year 2020 (PDF, 17.4 MB) A new technology coupled with a new biomarker test now in clinical trials are giving patients timely access to a quick, accurate and less invasive way to… Learn more
POSTED: 6/1/2020
SOURCE: Cancer Prevention Science Blog
A nurse consults with a patient during Coronavirus quarantine.
How Does COVID-19 Affect People with Cancer? NCCAPS Will Help Find Out
With the sudden explosion of the COVID-19 pandemic, we are all living with a great deal of fear, uncertainty, and anxiety. As an oncologist and cancer researcher, I know that those feelings are heightened for many people with cancer.
POSTED: 5/21/2020
SOURCE: NCI Cancer Currents Blog
3D illustration of the novel coronavirus.
Memos and Guidance for DCP Clinical Trials Investigators during the COVID-19 Pandemic
COVID-19 is an emerging, rapidly evolving situation. In addition to the information sources listed in the web header, the National Cancer Institute and the Division of Cancer Prevention have issued guidance for DCP investigators during the COVID-19 pandemic. Those materials are consolidated here… Learn more
POSTED: 5/7/2020
SOURCE: DCP News